Sinopharm is setting up production lines to supply up to one billion doses of two COVID-19 vaccines currently being tested on 50,000 people in Phase III trials. Sinopharm is currently testing the vaccines in ten countries, including Egypt, Argentina, Jordan, and Peru.
Sinopharm is setting up production lines to supply up to 1 billion doses of two COVID-19 vaccines currently being tested on 50,000 people in Phase III trials. Sinopharm is currently testing the vaccines in 10 countries including Egypt, Argentina, Jordan, and Peru.
Sinopharm is setting up production lines to supply up to one billion doses of two COVID-19 vaccines currently being tested on 50,000 people in Phase III trials. Sinopharm is currently testing the vaccines in ten countries, including Egypt, Argentina, Jordan, and Peru.
